BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534
43 results:

  • 1. Initial Evaluation of [
    Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
    J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A systematic literature review of the management, oncological outcomes and psychosocial implications of male breast cancer.
    Rutherford CL; Goodman D; Lannigan A
    Eur J Surg Oncol; 2022 Oct; 48(10):2104-2111. PubMed ID: 35725681
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Disparities in quality of life, social distress and employment outcomes in Australian cancer survivors.
    White VM; Lisy K; Ward A; Ristevski E; Clode M; Webber K; Emery J; Ijzerman MJ; Afshar N; Millar J; Gibbs P; Evans S; Jefford M
    Support Care Cancer; 2022 Jun; 30(6):5299-5309. PubMed ID: 35279769
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Upgrade Rates of Pure, Radiology-Pathology Concordant Lobular Neoplasia Diagnosed on breast Core Needle Biopsy: Is Surgical Excision Warranted?
    Karimi Z; Phillips J; Brook A; Baker G; Guzman Y; Mehta TS
    Acad Radiol; 2022 Jul; 29(7):1029-1038. PubMed ID: 34702673
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Occupational and patients effective radiation doses in dental imaging.
    Tamam N; Almuqrin AH; Mansour S; Elnour A; Musa M; Omer H; Sulieman A; Bradley DA
    Appl Radiat Isot; 2021 Nov; 177():109899. PubMed ID: 34438276
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Improving Global Surgical Oncology Benchmarks: Defining the Unmet Need for cancer Surgery in Ghana.
    Gaskill CE; Gyedu A; Stewart B; Quansah R; Donkor P; Mock C
    World J Surg; 2021 Sep; 45(9):2661-2669. PubMed ID: 34152449
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Distinct Classes of Flavonoids and Epigallocatechin Gallate, Polyphenol Affects an Oncogenic Mutant p53 Protein, Cell Growth and Invasion in a TNBC breast cancer Cell Line.
    Kollareddy M; Martinez LA
    Cells; 2021 Apr; 10(4):. PubMed ID: 33918387
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dysregulation of cancer genes by recurrent intergenic fusions.
    Yun JW; Yang L; Park HY; Lee CW; Cha H; Shin HT; Noh KW; Choi YL; Park WY; Park PJ
    Genome Biol; 2020 Jul; 21(1):166. PubMed ID: 32631391
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association of CAV1 polymorphisms with the risks of breast cancer: A systematic review and meta-analysis.
    Yan C; Sun C; Ding X; Rizeq FK; Ren M; Yang F; Chen Y; Wang B
    Pathol Res Pract; 2019 Sep; 215(9):152518. PubMed ID: 31303379
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Reclassification of
    Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
    J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. miR-17-5p suppresses cell proliferation and invasion by targeting etv1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.
    Eggemann H; Altmann U; Costa SD; Ignatov A
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):337-341. PubMed ID: 29098396
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of Adjuvant Chemotherapy on Left Ventricular Remodeling in Women with Newly Diagnosed Primary breast cancer: A Pilot Prospective Longitudinal Cardiac Magnetic Resonance Imaging Study.
    Avelar E; Truong QA; Inyangetor D; Marfatia R; Yang C; Kaloudis E; Tannenbaum S; Rosito G; Litwin S
    J Thorac Imaging; 2017 Nov; 32(6):365-369. PubMed ID: 28692525
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
    Cameron D; Morden JP; Canney P; Velikova G; Coleman R; Bartlett J; Agrawal R; Banerji J; Bertelli G; Bloomfield D; Brunt AM; Earl H; Ellis P; Gaunt C; Gillman A; Hearfield N; Laing R; Murray N; Couper N; Stein RC; Verrill M; Wardley A; Barrett-Lee P; Bliss JM;
    Lancet Oncol; 2017 Jul; 18(7):929-945. PubMed ID: 28600210
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries.
    Halpern MT; Schrag D
    Breast Cancer Res Treat; 2016 Aug; 158(3):573-81. PubMed ID: 27422241
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon cancer.
    Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
    N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. COP1, the negative regulator of etv1, influences prognosis in triple-negative breast cancer.
    Ouyang M; Wang H; Ma J; Lü W; Li J; Yao C; Chang G; Bi J; Wang S; Wang W
    BMC Cancer; 2015 Mar; 15():132. PubMed ID: 25884720
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients.
    Eggemann H; Ignatov A; Smith BJ; Altmann U; von Minckwitz G; Röhl FW; Jahn M; Costa SD
    Breast Cancer Res Treat; 2013 Jan; 137(2):465-70. PubMed ID: 23224235
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. er81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.
    Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL
    Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. etv1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
    Oh S; Shin S; Janknecht R
    Biochim Biophys Acta; 2012 Aug; 1826(1):1-12. PubMed ID: 22425584
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.